Cynthia Louise Flowers

Insider Reports History

Location
Basking Ridge, NJ
Signature
James Nisco, Attorney-in-Fact for Cynthia Louise Flowers
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Cynthia Louise Flowers:

Company Role Class Num Shares Value Price $ Report Date Ownership
LISATA THERAPEUTICS, INC. Director Common Stock 95,446 $224,298 $2.35 09 Jan 2026 Direct
G1 Therapeutics, Inc. Director Common Stock 0 $0 $2.51 18 Sep 2024 Direct
G1 Therapeutics, Inc. Director Stock Option (right to buy) 0 18 Sep 2024 Direct
Kadmon Holdings, Inc. Director Common Stock 0 $9.50 09 Nov 2021 Direct
Kadmon Holdings, Inc. Director Stock Option (right to buy) 0 $5.54 09 Nov 2021 Direct

Insider Reports Filed by Cynthia Louise Flowers

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LSTA LISATA THERAPEUTICS, INC. 09 Jan 2026 1 $0 4 Director 13 Jan 2026, 16:04
LSTA LISATA THERAPEUTICS, INC. 09 Jan 2025 1 $0 4 Director 13 Jan 2025, 16:03
/report/000095017024107798-flowers-cynthia-louise-2024-09-18 G1 Therapeutics, Inc. 18 Sep 2024 5 $0 4 Director 18 Sep 2024, 16:15
/report/000156218024005079-flowers-cynthia-louise-2024-06-13 G1 Therapeutics, Inc. 13 Jun 2024 2 $0 4 Director 14 Jun 2024, 16:39
LSTA LISATA THERAPEUTICS, INC. 09 Jan 2024 1 $0 4 Director 11 Jan 2024, 16:05
/report/000156218023005271-flowers-cynthia-louise-2023-06-15 G1 Therapeutics, Inc. 15 Jun 2023 2 $0 4 Director 16 Jun 2023, 16:07
LSTA LISATA THERAPEUTICS, INC. 09 Jan 2023 1 $0 4 Director 11 Jan 2023, 15:15
/report/000156218022005351-flowers-cynthia-louise-2022-06-23 G1 Therapeutics, Inc. 23 Jun 2022 2 $0 4 Director 24 Jun 2022, 16:51
LSTA CALADRIUS BIOSCIENCES, INC. 10 Jan 2022 1 $0 4 Director 12 Jan 2022, 15:10
/report/000110465921136411-flowers-cynthia-louise-2021-11-08 Kadmon Holdings, Inc. 08 Nov 2021 6 -$2,297,919 4 Director 09 Nov 2021, 16:41
/report/000156218021004397-schwalm-cynthia-2021-06-17 G1 Therapeutics, Inc. 17 Jun 2021 2 $0 4 Director 21 Jun 2021, 16:25
/report/000159396821001315-schwalm-cynthia-2021-05-12 Kadmon Holdings, Inc. 12 May 2021 1 $0 4 Director 13 May 2021, 16:17